Transpire Bio
Manufacturing · Florida, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2945 W Corporate Lakes Blvd Ste A, Westo...Website
www.transpirebio.comRevenue
$16.5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About Transpire Bio
Transpire Bio is a US-based, clinical-stage biopharmaceutical company specializing in proprietary inhalation formulation and delivery platforms that create new therapeutic opportunities. The company focuses on developing innovative biopharmaceuticals, co-development partnerships, and complex generics to address diseases with unmet needs. By leveraging their expertise in inhalation technology, they aim to enhance the effectiveness and tolerability of drugs with established benefits. Transpire Bio seeks to partner with investors and collaborators to maximize clinical value and reduce risk.Explore more
Transpire Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Transpire Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Transpire Bio has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Transpire Bio has new funding data
Website visits: Recent activity has been detected on your website
Click to see if Transpire Bio had a recent Job posting/layoffs
Product Launch: Get notified when Transpire Bio launches new products
Check out if Transpire Bio is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Transpire Bio
Transpire Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Transpire Bio recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Transpire Bio
Compare insights from companies similar to Transpire Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Transpire Bio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Transpire Bio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Transpire Bio.
Transpire Bio Tech Stack
A closer look at the technologies used by Transpire Bio
Most Recent Scoops
New Hire
Executive Move
R. LaDuane Clifton has recently joined the organization as Chief Financial Officer. Previously, Clifton served as Chief Financial Officer, Secretary & Treasurer for Zevra Therapeutics.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Open Position
Hiring Plans
Hiring Plans
Transpire Bio News & Media
Transpire Bio's ANDA for Generic High-Strength Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
SUNRISE, Fla., May 11, 2026 /PRNewswire/ -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company developing inhaled therapeutics for pulmonary and systemic diseases, today announces that its abbreviated new drug application (ANDA) for fluticasone furoate,...Transpire Bio Strengthens its Leadership Team with Appointment of Ewan Livesey as Head of Business Development
Transpire Bio Inc. today announced the appointment of Ewan Livesey as Head of Business DevelopmentTranspire Bio Strengthens its Leadership Team with Appointment of LaDuane Clifton as Chief Financial Officer
SUNRISE, Fla., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced the appointment of R. LaDuane Clifton as Chief Financial Officer (CFO).Transpire Bio’s ANDA for Generic Trelegy® Ellipta® Accepted for Filing by the U.S. FDA
SUNRISE, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announces that its abbreviated new drug application (ANDA) for fluticasone furoate, umeclidinium, and vilanterol inhalation powder, a generic version of Trelegy® Ellipta®1 100/62.5/25, has been accepted for filing by the U.S. Food and Drug Administration (FDA). Based on the FDA’s public records
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Transpire Bio
Sign Up For FreeTo access detailed company insights
Transpire Bio is a US-based, clinical-stage biopharmaceutical company specializing in proprietary inhalation formulation and delivery platforms that create new therapeutic opportunities. The company focuses on developing innovative biopharmaceuticals, co-development partnerships, and complex generics to address diseases with unmet needs. By leverag... Read More
